NIELSEN HOLDINGS PLC (NLSN) 27.98 +0.01 (+0.04%)
27.98 +0.01 (+0.04%)
GB00BWFY5505 - Common Stock - After market: 27.99 +0.01 (+0.04%)
Fundamental Rating
We assign a fundamental rating of 4 out of 10 to NLSN. NLSN was compared to 70 industry peers in the Professional Services industry. Both the profitability and the financial health of NLSN get a neutral evaluation. Nothing too spectacular is happening here. NLSN is valued expensive and it does not seem to be growing.
Profitability
Profitability Rating
NLSN has a Profit Margin of 14.99%. This is amongst the best returns in the industry. The industry average is 6.71%. NLSN outperforms 89% of its industry peers.
NLSN's Return On Assets of 4.86% is in line with the rest of the industry. The industry average Return On Assets is 5.21%.
NLSN has a Piotroski-F score of 6.00. This indicates an average health and profitability for NLSN.
NLSN's Return On Equity of 15.26% is worse than the rest of the industry. The industry average Return On Equity is 18.47%.
VS Industry
ROA (4.86%) VS Industry: 48% outperformed.
-415.60
46.57
ROE (15.26%) VS Industry: 35% outperformed.
0.52
249.34
Profit Margin (14.99%) VS Industry: 89% outperformed.
0.20
37.19
Valuation
Valuation Rating
The Price/Earnings Ratio is 15.37, which indicates a correct valuation of NLSN.
Compared to an average industry Price/Earning Ratio of 16.40, NLSN is valued in line with its industry peers.
The Forward Price/Earnings Ratio of 13.98 indicates a correct valuation of NLSN.
With a price book ratio of 2.90, NLSN is valued correctly.
When comparing the price book ratio of NLSN to the average industry price book ratio of 2.41, NLSN is valued in line with its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 12.63, NLSN is valued in line with its industry peers.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VS Industry
Price/Earnings (15.37) VS Industry: 54% outperformed.
1,210.50
1.98
Price/Book (2.9) VS Industry: 43% outperformed.
72.71
0.04
Enterprise Value/ EBITDA (11.18) VS Industry: 55% outperformed.
48.62
0.29
Growth
Growth Rating
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The earnings per share for NLSN have decreased by -2.15% in the last year.
The Earnings Per Share has been decreasing by -6.84% on average over the past 5 years.
NLSN is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 5.62% yearly.
The Revenue is expected to grow by 3.21% on average over the next 5 years.
The Revenue for NLSN has decreased by -28.72% in the past year. This is quite bad
Measured over the past 5 years, NLSN shows a very negative growth in Revenue. The Revenue has been decreasing by -11.12% on average per year.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | -6.84% | 23.97% | -2.15% | 6.17% | 5.15% | 6.05% | 5.62% |
| Revenue | -11.12% | -18.71% | -28.72% | 2.38% | 3.15% | 3.41% | 3.21% |
Health
Health Rating
NLSN has a Current Ratio of 2.04. This indicates that NLSN is financially healthy and has no problem in meeting its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 1.43, NLSN is better placed than the average industry peer to meet its short term obligations.
NLSN has a Quick Ratio of 2.04. This indicates that NLSN is financially healthy and has no problem in meeting its short term obligations.
The Quick Ratio of NLSN is much better than the industry average of 1.43.
The Piotroski-F score of NLSN is 6.00. This is a neutral score and indicates average health and profitability for NLSN.
Compared to an average industry Debt to Equity Ratio of 0.35, NLSN is requires more financing than its industry peers. 94% of its industry peers have a better Debt to Equity Ratio.
Based on the Altman-Z score of 1.46, we must say that NLSN is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of NLSN to the average industry Altman-Z score of 3.17, NLSN is less financially healthy than its industry peers.
VS Industry
Debt/Equity (1.61) VS Industry: 6% outperformed.
6.11
0.00
Quick Ratio (2.04) VS Industry: 71% outperformed.
0.17
15.36
Current Ratio (2.04) VS Industry: 71% outperformed.
0.17
15.36
Altman-Z (1.46) VS Industry: 22% outperformed.
-47.05
45.17
Dividend
Dividend Rating
NLSN pays out 16.23% of its income as dividend. This is a sustainable payout ratio.
NLSN has been paying a dividend for over 5 years, so it has already some track record.
With a yearly dividend of 0.86%, NLSN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.48, NLSN's dividend is way lower than its industry peers. On top of this 80% of the companies listed in the same industry pay a better dividend than NLSN!
Compared to an average S&P500 Dividend Yield of 2.43, NLSN's dividend is way lower than the S&P500 average.
The dividend of NLSN decreases each year by -44.32%.
VS Industry
Dividend Yield (0.86%) VS Industry: 20% outperformed.
0.50
4.51
NIELSEN HOLDINGS PLC27.98
NYSE:NLSN (10/11/2022, 7:25:24 PM)+0.01 (+0.04%)
| GICS Sector | Industrials | ||
| GICS IndustryGroup | Commercial & Professional Services | ||
| GICS Industry | Professional Services | ||
| Earnings (Last) | 07-27 2022-07-27/bmo | Earnings (Next) | 11-04 2022-11-04/bmo |
| Ins Owners | 0.01% | Inst Owners | 98.37% |
| Market Cap | 10.07B | Analysts | 71.43 |
| PE | 15.37 | Fwd PE | 13.98 |
| PEG (NY) | 2.49 | PEG (5Y) | N/A |
| P/S | 2.85 | P/B | 2.9 |
| EV/EBITDA | 11.18 | ||
| Dividend Yield | 0.86% | Dividend Growth | -44.32% |
| DP | 16.23% | Ex-Date | 08-17 2022-08-17 (0.06) |
| EPS 1Y | -2.15% | EPS 3Y | 23.97% |
| EPS 5Y | -6.84% | EPS growth Q2Q | 6.98% |
| EPS Next Y | 6.17% | EPS Next 2Y | 5.15% |
| EPS Next 3Y | 6.05% | EPS Next 5Y | 5.62% |
| Revenue growth 1Y | -28.72% | Revenue growth 3Y | -18.71% |
| Revenue growth 5Y | -11.12% | Revenue growth Q2Q | 2.44% |
| Revenue Next Year | 2.38% | Revenue Next 2Y | 3.15% |
| Revenue Next 3Y | 3.41% | Revenue Next 5Y | 3.21% |
| Current Ratio | 2.04 | Quick Ratio | 2.04 |
| Altman-Z | 1.46 | F-Score | 6 |
| Debt/Equity | 1.61 | WACC | 7.27% |
| ROIC/WACC | 7.09 | ||
| ROA | 4.86% | ROE | 15.26% |
| ROICexgc | 51.61% | ROIC | 6.42% |
| PM | 14.99% | OM | 23.51% |
| Asset Turnover | 0.32 | ||
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA